We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.02B
AUM Growth
+$5.4M
Cap. Flow
-$164M
Cap. Flow %
-16.09%
Top 10 Hldgs %
38.61%
Holding
122
New
34
Increased
17
Reduced
32
Closed
31

Top Buys

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$17.8M
2
NVDA icon
NVIDIA
NVDA
+$15.9M
3
CEG icon
Constellation Energy
CEG
+$13.4M
4
TSM icon
TSMC
TSM
+$12.1M
5
AAPL icon
Apple
AAPL
+$11.2M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$37.3M
2
INTC icon
Intel
INTC
+$14.1M
3
AMD icon
Advanced Micro Devices
AMD
+$11.9M
4
ALPN
Alpine Immune Sciences Inc
ALPN
+$10.1M
5
CELH icon
Celsius Holdings
CELH
+$9.95M

Sector Composition

Rank Sector Weight
1 Technology 29.18%
2 Healthcare 26.79%
3 Consumer Discretionary 8.41%
4 Industrials 8.14%
5 Communication Services 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DASH icon
51
DoorDash
DASH
$92.4B
$6.85M 0.67%
63,000
-12,000
-16% -$1.45M
ITCI
52
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.68M 0.65%
97,500
-7,500
-7% -$520K
XBI icon
53
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$6.68M 0.65%
+720
New +$64.6K
DYN icon
54
Dyne Therapeutics
DYN
$4.83B
$6.41M 0.63%
181,500
+6,500
+4% +$189K
NBIX icon
55
Neurocrine Biosciences
NBIX
$16.2B
$6.13M 0.6%
44,500
-13,500
-23% -$1.85M
VRTX icon
56
Vertex Pharmaceuticals
VRTX
$123B
$6.09M 0.6%
+13,000
New +$5.64M
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$28.9B
$5.95M 0.58%
+24,500
New +$3.87M
ASML icon
58
ASML
ASML
$655B
$5.83M 0.57%
+5,700
New +$5.48M
URA icon
59
CALL
Global X Uranium ETF
URA
$5.99B
$5.79M 0.57%
+2,000
New +$60.9K
FERG icon
60
Ferguson
FERG
$49.1B
$5.67M 0.56%
29,300
– –
SBUX icon
61
CALL
Starbucks
SBUX
$120B
$5.61M 0.55%
+720
New +$58.6K
TBBB icon
62
BBB Foods
TBBB
$4.9B
$5.37M 0.53%
225,000
+71,000
+46% +$1.66M
BECN
63
DELISTED
Beacon Roofing Supply, Inc.
BECN
$5.11M 0.5%
56,500
+26,500
+88% +$2.56M
XENE icon
64
Xenon Pharmaceuticals
XENE
$6.24B
$4.83M 0.47%
124,000
+2,000
+2% +$79.9K
MRNA icon
65
PUT
Moderna
MRNA
$21.5B
$4.75M 0.47%
+400
New +$50.6K
ENPH icon
66
Enphase Energy
ENPH
$5.24B
$4.39M 0.43%
44,000
– –
BBIO icon
67
CALL
BridgeBio Pharma
BBIO
$16.2B
$4.36M 0.43%
1,720
– –
ROIV icon
68
Roivant Sciences
ROIV
$25.4B
$4.23M 0.41%
400,000
-134,980
-25% -$1.48M
S icon
69
CALL
SentinelOne
S
$7.12B
$4.21M 0.41%
+2,000
New +$41K
MNDY icon
70
monday.com
MNDY
$3.7B
$4.09M 0.4%
17,000
-46,000
-73% -$9.7M
AXSM icon
71
Axsome Therapeutics
AXSM
$10.8B
$3.94M 0.39%
49,000
-19,000
-28% -$1.41M
GTLB icon
72
GitLab
GTLB
$6.03B
$3.88M 0.38%
+78,000
New +$4.05M
TMDX icon
73
Transmedics
TMDX
$2.78B
$3.61M 0.35%
+24,000
New +$2.88M
NTRA icon
74
Natera
NTRA
$38B
$3.25M 0.32%
+30,010
New +$3.05M
P
75
PUT
Everpure Inc
P
$29B
$3.21M 0.31%
+500
New +$28.9K
1 2
3
4 5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

Atika Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Atika Capital Management held 122 positions worth $1.02B, up 0.53% from $1.02B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Atika Capital Management withdrew a net $164M in Q2 2024, closing 31 positions and reducing 32 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $37.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Atika Capital Management opened a new position in Spotify worth $18.5M.

  • Atika Capital Management's largest Q2 2024 buy was Spotify: 59,000 shares worth $18.5M.
  • Atika Capital Management added most to NVIDIA in Q2 2024, an estimated $15.9M increase.
  • Atika Capital Management's biggest Q2 2024 reduction was monday.com, cutting an estimated $9.7M.
  • Atika Capital Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $37.3M.
  • Atika Capital Management's ten largest holdings make up 39% of its $1.02B portfolio in Q2 2024.
  • Atika Capital Management opened 34 new positions and closed 31 in Q2 2024.
  • Atika Capital Management's portfolio value rose 0.53% quarter-over-quarter to $1.02B.

Based on Atika Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.